BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 2572488)

  • 1. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O; Akinyemi A
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of three oral contraceptives in Ibadan: Norinyl 1/35, Lo-Ovral and Noriday 1/50.
    Otolorin EO; Falase EA; Ladipo OA
    Afr J Med Med Sci; 1990 Mar; 19(1):15-22. PubMed ID: 2109515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double blind study of two oral contraceptives.
    Sanhueza H; Sivin I; Kumar S; Kessler M; Carrasco A; Yee J
    Contraception; 1979 Jul; 20(1):29-48. PubMed ID: 477315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative trials of low-dose combined oral contraceptives.
    Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
    J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of Norinyl and Brevicon in three sites in Sri Lanka.
    Basnayake S; de Silva SV; Miller PC; Rogers S
    Contraception; 1983 May; 27(5):453-64. PubMed ID: 6884024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The probability of side effects with ovral, norinyl 1/50 and norlestrin.
    Berger GS; Edelman DA; Talwar PP
    Contraception; 1979 Nov; 20(5):447-53. PubMed ID: 160860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of 35 mcg and 50 mcg combined oral contraceptives: results from a multicenter clinical trial.
    McLaurin VL; Dunson BA; Dunson TR
    Contraception; 1991 Nov; 44(5):489-503. PubMed ID: 1797464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of standard-dose and low-dose oral contraceptives in rural Bangladesh.
    Bairagi R; Razzaque A; Obaidullah M; Measham AR; Khan AR
    Int J Gynaecol Obstet; 1980; 18(4):264-7. PubMed ID: 6109670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial.
    Dunson TR; McLaurin VL; Israngkura B; Leelapattana B; Mukherjee R; Perez-Palacios G; Saleh AA
    Contraception; 1993 Aug; 48(2):109-19. PubMed ID: 8403908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A crossover pill study among Sudanese women.
    Gerais AS; Rushwan H
    Int J Gynaecol Obstet; 1985 Jun; 23(3):229-33. PubMed ID: 2865187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
    Dunson TR; McLaurin VL; Aguayo EL; de Silva P; Calventi V; Gerais AS; Serani RG
    Contraception; 1993 Jun; 47(6):515-25. PubMed ID: 8334888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative clinical trial of Norinyl 1/35 versus Brevicon in Rio Clara, Brazil.
    Albuquerque LA; Albuquerque EG; Waszak CS; Rowan AJ; Barthlow D
    Contraception; 1988 Nov; 38(5):525-39. PubMed ID: 3058383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of Norinyl 1/35 versus Norinyl 1/50 in Belgrade, Yugoslavia.
    Behilovic B; Rowan AJ
    Contraception; 1987 Nov; 36(5):515-26. PubMed ID: 3329079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
    Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Gaspard UJ; Deville JL; Dubois M
    Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of high-dose estrogens versus low-dose ethinylestradiol and norgestrel combination in postcoital interception: a study in 493 women.
    Van Santen MR; Haspels AA
    Fertil Steril; 1985 Feb; 43(2):206-13. PubMed ID: 3881294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.